Wide Ranks

ARAY

Accuray Incorporated

2.11

Top Statistics
Market Cap 212 M Forward PE 15.07 Revenue Growth 16.80 %
Current Ratio 1.63 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -3.72 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 60.75 Enterprise / Revenue 0.6650 Price To Sales Trailing12 Months 0.4777
Profitability
Profit Margins -3.72 % Operating Margins 3.73 %
Balance Sheet
Total Cash 116 M Total Cash Per Share 1.16 Total Debt 199 M
Total Debt To Equity 289.67 Current Ratio 1.63 Book Value Per Share 0.4500
All Measures
Short Ratio 554.00 % Message Board Id finmb_739115 Fax 608 824 2996
Shares Short Prior Month 4 M Return On Equity -0.3438 City Madison
Uuid 64cb6c33-f544-31fe-a9fb-15146526be36 Previous Close 1.96 First Trade Date Epoch Utc 1 B
Book Value 0.4500 Beta 1.40 Total Debt 199 M
Volume 622863 Price To Book 4.69 Fifty Two Week Low 1.40
Total Cash Per Share 1.16 Total Revenue 444 M Shares Short Previous Month Date 1 B
Target Median Price 6.00 Max Age 86400 Recommendation Mean 1.25
Sand P52 Week Change 0.3133 Operating Margins 3.73 % Target Mean Price 6.12
Net Income To Common -16530000 Short Percent Of Float 0.0367 Implied Shares Outstanding 100 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 646440
Average Volume10days 646440 Total Cash 116 M Next Fiscal Year End 1 B
Revenue Per Share 4.48 Held Percent Insiders 0.0283 Ebitda Margins 1.09 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.96 Target Low Price 5.50 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.84 Open 1.97 Free Cashflow -3687875
State WI Dividend Yield 0.00 % Return On Assets -0.0017
Time Zone Short Name EST Trailing Eps -0.1700 Day Low 1.96
Address1 1240 Deming Way Shares Outstanding 100 M Price Hint 4
Target High Price 7.00 Website https://www.accuray.com 52 Week Change -0.1916
Average Volume 633676 Forward Eps 0.1200 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 75.30 % Is_sp_500 False
Regular Market Day High 2.12 Profit Margins -3.72 % Debt To Equity 289.67
Fifty Two Week High 3.05 Day High 2.12 Shares Short 3 M
Regular Market Open 1.97 Industry Key medical-devices Earnings Growth 0.00 %
Enterprise To Revenue 0.6650 Revenue Growth 16.80 % Shares Percent Shares Out 0.0358
Operating Cashflow -10607000 Currency USD Time Zone Full Name America/New_York
Market Cap 212 M Is_nasdaq_100 False Zip 53717-1954
Quote Type EQUITY Industry Medical Devices Long Name Accuray Incorporated
Regular Market Day Low 1.96 Held Percent Institutions 0.6259 Current Price 2.11
Enterprise To Ebitda 60.75 Financial Currency USD Current Ratio 1.63
Gross Margins 31.09 % Industry Disp Medical Devices Number Of Analyst Opinions 4
Country United States Float Shares 97 M Two Hundred Day Average 2.01
Ir Website http://investors.accuray.com/phoenix.zhtml?c=177244&p=irol-irhome Enterprise Value 295 M Price To Sales Trailing12 Months 0.4777
Forward PE 15.07 Regular Market Volume 622863 Ebitda 4 M
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.

The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.

In addition, it offers post-contract customer support, installation, training, and other professional services.

The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally.

Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.